32477152|t|Neuroprotective Effects of Fluoxetine Against Chronic Stress-Induced Neural Inflammation and Apoptosis: Involvement of the p38 Activity.
32477152|a|Depression is considered a widespread neuropsychiatric disease associated with neuronal injury within specific brain regions. Fluoxetine, a selective serotonin reuptake inhibitor, has been widely used in depressed patients. Recently, fluoxetine has demonstrated neuroprotective effects apart from the effect on serotonin. However, the underlying mechanism involved in this neuroprotection remains unclear, in particular, whether fluoxetine exerts antidepressant effects via protecting against neuronal injury. Here, we found that treatment with fluoxetine (10 mg/kg, i.p.) for 2 weeks ameliorated depression-like behaviors in a chronic unpredictable mild stress (CUMS)-induced rat model of depression and was accompanied with an alleviation of glia activation and inhibition of interleukin-1beta (IL-1beta), interferon gamma (IFN-gamma), and tumor necrosis factor-alpha (TNF-alpha) expression in the hippocampal dentate gyrus (DG) region. Meanwhile, CUMS rats treated with fluoxetine showed reductions in neuronal apoptosis and a downregulation of the apoptotic protein Bax, cleaved caspase 3, and caspase 9 levels. These effects appear to involve a downregulation of p38 mitogen-activated protein kinase (MAPK) signaling within the DG hippocampus as the specific inhibitor of p38 MAPK, SB203580, significantly suppressed apoptosis, as well as ameliorated depressive behaviors resulting from CUMS exposure. Moreover, fluoxetine could rescue neuronal deterioration and depression-like phenotypes caused by overexpression of p38 in DG. This finding extends our knowledge on the antidepressant-like effects of fluoxetine, which appear to at least partially profit from neuroprotection against inflammation and neuronal apoptosis via downregulation of the p38 MAPK pathway. The neuroprotective mechanisms of fluoxetine may provide some novel therapeutic avenues for stress-related neurological diseases.
32477152	27	37	Fluoxetine	Chemical	MESH:D005473
32477152	76	88	Inflammation	Disease	MESH:D007249
32477152	123	126	p38	Gene	81649
32477152	137	147	Depression	Disease	MESH:D003866
32477152	175	199	neuropsychiatric disease	Disease	MESH:D004194
32477152	216	231	neuronal injury	Disease	MESH:D009410
32477152	263	273	Fluoxetine	Chemical	MESH:D005473
32477152	287	305	serotonin reuptake	Chemical	-
32477152	341	350	depressed	Disease	MESH:D003866
32477152	351	359	patients	Species	9606
32477152	371	381	fluoxetine	Chemical	MESH:D005473
32477152	448	457	serotonin	Chemical	MESH:D012701
32477152	566	576	fluoxetine	Chemical	MESH:D005473
32477152	630	645	neuronal injury	Disease	MESH:D009410
32477152	682	692	fluoxetine	Chemical	MESH:D005473
32477152	734	744	depression	Disease	MESH:D003866
32477152	765	798	chronic unpredictable mild stress	Chemical	-
32477152	800	804	CUMS	Chemical	-
32477152	814	817	rat	Species	10116
32477152	827	837	depression	Disease	MESH:D003866
32477152	915	932	interleukin-1beta	Gene	24494
32477152	934	942	IL-1beta	Gene	24494
32477152	945	961	interferon gamma	Gene	25712
32477152	963	972	IFN-gamma	Gene	25712
32477152	979	1006	tumor necrosis factor-alpha	Gene	24835
32477152	1008	1017	TNF-alpha	Gene	24835
32477152	1087	1091	CUMS	Chemical	-
32477152	1092	1096	rats	Species	10116
32477152	1110	1120	fluoxetine	Chemical	MESH:D005473
32477152	1142	1160	neuronal apoptosis	Disease	MESH:D065703
32477152	1207	1210	Bax	Gene	24887
32477152	1220	1229	caspase 3	Gene	25402
32477152	1235	1244	caspase 9	Gene	58918
32477152	1305	1341	p38 mitogen-activated protein kinase	Gene	81649
32477152	1424	1432	SB203580	Chemical	MESH:C093642
32477152	1493	1513	depressive behaviors	Disease	MESH:D011596
32477152	1529	1533	CUMS	Chemical	-
32477152	1554	1564	fluoxetine	Chemical	MESH:D005473
32477152	1578	1600	neuronal deterioration	Disease	MESH:D009410
32477152	1605	1615	depression	Disease	MESH:D003866
32477152	1660	1663	p38	Gene	81649
32477152	1744	1754	fluoxetine	Chemical	MESH:D005473
32477152	1827	1839	inflammation	Disease	MESH:D007249
32477152	1844	1862	neuronal apoptosis	Disease	MESH:D065703
32477152	1941	1951	fluoxetine	Chemical	MESH:D005473
32477152	2014	2035	neurological diseases	Disease	MESH:D020271
32477152	Negative_Correlation	MESH:D005473	24494
32477152	Negative_Correlation	MESH:D005473	MESH:D020271
32477152	Negative_Correlation	MESH:C093642	MESH:D011596
32477152	Negative_Correlation	MESH:D005473	MESH:D003866
32477152	Association	MESH:D009410	81649
32477152	Negative_Correlation	MESH:D005473	58918
32477152	Negative_Correlation	MESH:D005473	MESH:D065703
32477152	Negative_Correlation	MESH:D005473	25712
32477152	Association	MESH:D005473	MESH:D012701
32477152	Negative_Correlation	MESH:D005473	24835
32477152	Negative_Correlation	MESH:D005473	24887
32477152	Negative_Correlation	MESH:D005473	MESH:D009410
32477152	Association	MESH:D005473	81649
32477152	Negative_Correlation	MESH:D005473	25402
32477152	Negative_Correlation	MESH:D005473	MESH:D007249
32477152	Association	MESH:D003866	81649

